RBC Capital Maintains Outperform on Verastem, Lowers Price Target to $16
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Gregory Renza maintains an Outperform rating on Verastem (NASDAQ:VSTM) but lowers the price target from $32 to $16.
May 28, 2024 | 12:11 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
RBC Capital's analyst Gregory Renza maintains an Outperform rating on Verastem but lowers the price target from $32 to $16, indicating a more conservative outlook on the stock's potential.
The Outperform rating suggests continued confidence in Verastem's performance, but the lowered price target indicates a more cautious approach. This mixed signal may result in neutral short-term price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100